The trading price of Lantern Pharma Inc (NASDAQ:LTRN) closed higher on Tuesday, July 08, and closing at $3.54, 12.38% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $3.36 and $3.73. In examining the 52-week price action we see that the stock hit a 52-week high of $6.12 and a 52-week low of $2.55. Over the past month, the stock has gained 3.21% in value.
Lantern Pharma Inc, whose market valuation is $38.18 million at the time of this writing, is expected to release its quarterly earnings report on 2025-May-15. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest LTRN has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned LTRN a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Lantern Pharma Inc (LTRN) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that LTRN’s price is currently 10.18% off the SMA20 and 4.07% off the SMA50. The RSI metric on the 14-day chart is currently showing 60.11, and weekly volatility stands at 6.72%. When measured over the past 30 days, the indicator reaches 5.80%. Lantern Pharma Inc (NASDAQ:LTRN)’s beta value is currently sitting at 1.56.
To see how Lantern Pharma Inc stock has been performing in comparison to its peers in the industry, here are the numbers: LTRN stock’s performance was 12.38% in the latest trading, and 10.97% in the past year.
An evaluation of the daily trading volume of Lantern Pharma Inc (NASDAQ:LTRN) indicates that the 3-month average is 58.10K. However, this figure has increased over the past 10 days to an average of 0.41.
Currently, records show that 10.78 million of the company’s shares remain outstanding. The insiders hold 24.31% of outstanding shares, whereas institutions hold 11.37%. The stats also highlight that short interest as of 2025-06-13, stood at 0.28 million shares, resulting in a short ratio of 3.77 at that time. From this, we can conclude that short interest is 291.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were up slightly from the previous month’s figure, which was 0.25 million. However, since the stock’s price has seen -17.48% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
